Strategies to address low drug solubility in discovery and development

HD Williams, NL Trevaskis, SA Charman… - Pharmacological …, 2013 - ASPET
Drugs with low water solubility are predisposed to low and variable oral bioavailability and,
therefore, to variability in clinical response. Despite significant efforts to “design in” …

Current drug therapy and pharmaceutical challenges for Chagas disease

J Bermudez, C Davies, A Simonazzi, JP Real, S Palma - Acta tropica, 2016 - Elsevier
One of the most significant health problems in the American continent in terms of human
health, and socioeconomic impact is Chagas disease, caused by the protozoan parasite …

Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions

F Meng, A Trivino, D Prasad, H Chauhan - European Journal of …, 2015 - Elsevier
Curcumin (CUR) was used as a poorly soluble drug whereas polyvinyl pyrrolidone K90
(PVP), Eudragit EPO (EPO), hydroxypropyl methylcellulose E5 (HPMC) and polyethylene …

[HTML][HTML] ZIF-8 as a promising drug delivery system for benznidazole: development, characterization, in vitro dialysis release and cytotoxicity

LR de Moura Ferraz, AÉGA Tabosa… - Scientific reports, 2020 - nature.com
Chagas disease (CD), caused by the flagellate protozoan Trypanosoma cruzi, is one of the
major public health problems in developing countries. Benznidazole (BNZ) is the only drug …

[HTML][HTML] Molecular interactions in solid dispersions of poorly water-soluble drugs

TTD Tran, PHL Tran - Pharmaceutics, 2020 - mdpi.com
Physicochemical characterization is a crucial step for the successful development of solid
dispersions, including the determination of drug crystallinity and molecular interactions …

Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods

LDS Alves, MFLR Soares, CT de Albuquerque… - Carbohydrate …, 2014 - Elsevier
Efavirenz (EFV) used as a part of the treatment of first choice in antiretroviral therapy for
AIDS has low aqueous solubility and presents problems of absorption. We thus initially …

First century of chagas' disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems

CJ Salomon - Journal of Pharmaceutical Sciences, 2012 - Elsevier
Hundred years after the discovery of Chagas' disease, there is a lack of effective treatment to
control this neglected disease caused by the parasite Trypanosoma cruzi. The transmission …

Role of molecular interactions for synergistic precipitation inhibition of poorly soluble drug in supersaturated drug–polymer–polymer ternary solution

D Prasad, H Chauhan, E Atef - Molecular pharmaceutics, 2016 - ACS Publications
We are reporting a synergistic effect of combined Eudragit E100 and PVP K90 in
precipitation inhibition of indomethacin (IND) in solutions at low polymer concentration, a …

A comparison of the crystallization inhibition properties of bile salts

N Li, LI Mosquera-Giraldo, CH Borca… - Crystal Growth & …, 2016 - ACS Publications
Bile salts are natural surfactants present in the human gastrointestinal tract. Therefore, it is
essential to consider their effect on the dissolution and crystallization tendency of oral drug …

Development and characterization of benznidazole nano-and microparticles: a new tool for pediatric treatment of Chagas disease?

KP Seremeta, EC Arrúa, NB Okulik… - Colloids and Surfaces B …, 2019 - Elsevier
Benznidazole (BNZ) is the drug of choice for the treatment of Chagas disease in many
countries. However, its low water solubility produces low and/or variable oral bioavailability …